https://www.worldpharmatoday.com/press-releases/updated-label-for-daklinza-daclatasvir-for-the-12-week-treatment-of-non-cirrhotic-patients-with-chronic-hepatitis-c-genotype-3-approved-by-the-european-commission/ Magazine for the C-level Pharma Executives Wed, 09 Sep 2015 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4